Προνομιακή μεταχείριση Σοβαρός Θέλω ioannis zerdes ευφραδής Δώστε δικαιώματα Ατομικότητα
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes m diplom | Pfizer Sverige
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes får nytt stipendium för sin bröstcancerforskning
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
maria ekholm o Ioannis zerdes | Pfizer Sverige
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer
De är först att få nytt stipendium för cancerforskning
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
The interplay between eosinophils and T cells in breast cancer immunotherapy - Zerdes - 2023 - Molecular Oncology - Wiley Online Library
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile